Second, lnc-MAFG-AS1 regulates the drug resistance of HCC, which then affects the preoperative and postoperative treatment response, or the response to therapy after relapse, to directly relate to HCC prognosis (15). Here, MAFG is linked to hepatocellular carcinoma.